rs143473912
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM2PM5PP3PP5_Very_Strong
The NM_000359.3(TGM1):c.944G>T(p.Arg315Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000031 in 1,611,804 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R315C) has been classified as Pathogenic.
Frequency
Consequence
NM_000359.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TGM1 | ENST00000206765.11 | c.944G>T | p.Arg315Leu | missense_variant | 6/15 | 1 | NM_000359.3 | ENSP00000206765.6 | ||
TGM1 | ENST00000559136.1 | c.17G>T | p.Arg6Leu | missense_variant | 2/7 | 5 | ENSP00000453337.1 | |||
TGM1 | ENST00000544573.5 | c.-28-1356G>T | intron_variant | 2 | ENSP00000439446.1 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152086Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000406 AC: 10AN: 246144Hom.: 0 AF XY: 0.0000225 AC XY: 3AN XY: 133622
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1459718Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 8AN XY: 726038
GnomAD4 genome AF: 0.000191 AC: 29AN: 152086Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74274
ClinVar
Submissions by phenotype
Autosomal recessive congenital ichthyosis 1 Pathogenic:9
Pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Jan 03, 2017 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Pathogenic, criteria provided, single submitter | research | Division of Human Genetics, National Health Laboratory Service/University of the Witwatersrand | Jul 01, 2023 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 01, 2010 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Oct 22, 2018 | The TGM1 c.944G>T (p.Arg315Leu) missense variant has been reported in three studies in which it is found in a total of 11 individuals with congenital ichthyosis including in ten in a homozygous state and in one in a compound heterozygous state (Tok et al. 1999; Arita et al. 2007; Hackett et al. 2010). The variant is also found in one unaffected parent in a heterozygous state (Tok et al. 1999). The p.Arg315Leu variant has been associated with a specific phenotype of ichthyosis referred to as bathing suit ichthyosis (Arita et al. 2007; Hackett et al. 2010). The p.Arg315Leu variant was absent from at least 150 control chromosomes (Arita et al. 2007; Hackett et al. 2010) and is reported at a frequency of 0.00061 in the African population of the Exome Aggregation Consortium. Testing in NHEK cells found that the p.Arg315Leu variant demonstrated increased protein stability, increased half-life and prevented proteolytic processing into the active form of the enzyme (Candi et al. 1998). The specific activity of the unprocessed form was similar to wild type, however due to the lack of processing the variant protein could not be converted into the highly active form, unlike wild type (Candi et al. 1998). The Arg315 residue is highly conserved and is located in a catalytic core domain (Arita et al. 2007). Based on the evidence, the p.Arg315Leu variant is classified as pathogenic for congenital ichthyosis. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 27, 2024 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jul 10, 2020 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | - | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 27, 2023 | Published functional studies demonstrate a damaging effect with impaired proteolytic processing, reduced activity of membrane-bound transglutaminase 1 in keratinocytes, and enhanced stability of the mutant protein; variant described using alternate nomenclature as R314L (Candi et al., 1998; Trindade et al., 2010); This variant is associated with the following publications: (PMID: 31168818, 28403434, 19863506, 20522418, 10232404, 31589614, 35698621, 16977323, 9593710) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 05, 2024 | This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 315 of the TGM1 protein (p.Arg315Leu). This variant is present in population databases (rs143473912, gnomAD 0.06%). This missense change has been observed in individuals with TGM1-related disease (PMID: 10232404, 16977323, 19863506, 20522418, 28403434). ClinVar contains an entry for this variant (Variation ID: 39531). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TGM1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects TGM1 function (PMID: 9593710). This variant disrupts the p.Arg315 amino acid residue in TGM1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 10232404, 16977323, 19863506, 20522418, 28403434). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
TGM1-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 27, 2024 | The TGM1 c.944G>T variant is predicted to result in the amino acid substitution p.Arg315Leu. This variant has been previously reported in the homozygous or compound heterozygous state in patients with ichthyosis (Arita et al. 2007. PubMed ID: 16977323; Trindade et al. 2010. PubMed ID: 20522418; Hackett et al. 2010. PubMed ID: 19863506; Table S2, Simpson et al 2019. PubMed ID: 31168818; Marukian et al 2017. PubMed ID: 28403434). This variant is reported in 0.053% of alleles in individuals of African descent in gnomAD. This variant is interpreted as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at